Fixel-Based Analysis of Pretreatment MRI Identifies White Matter Abnormalities in Pediatric Anti-NMDAR Encephalitis

Daniel Ackom1, Janine Taitt-Tap2, Scott A Beardsley1,2

  • 1Joint Department of Biomedical Engineering, Marquette University and Medical College of Wisconsin, Milwaukee, WI, USA.

Insights

Fixel-based analysis (FBA) detects white matter abnormalities in pediatric anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis, even when conventional MRI is normal. This advanced MRI technique aids in diagnosing and monitoring this autoimmune brain disorder.

Area of Science:

  • Neuroscience
  • Radiology
  • Immunology

Background:

  • Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is an autoimmune disorder.
  • Conventional MRI often shows normal findings, causing clinical-radiologic dissociation and diagnostic delays.

Purpose of the Study:

  • To investigate the utility of fixel-based analysis (FBA) in detecting white matter abnormalities in pediatric anti-NMDAR encephalitis.
  • To compare pretreatment diffusion MRI findings using FBA with age- and sex-matched controls.

Main Methods:

  • Retrospective study of five pediatric patients with anti-NMDAR encephalitis.
  • Application of fixel-based analysis (FBA) to quantify tract-specific white matter abnormalities on diffusion MRI.
  • Comparison with age- and sex-matched control subjects.

Main Results:

  • All patients exhibited significantly reduced white matter fiber density and cross-section.
  • FBA identified focal to widespread white matter involvement.
  • In two patients, FBA findings correlated with EEG seizure lateralization, despite normal conventional MRI.

Conclusions:

  • Fixel-based analysis (FBA) can identify significant white matter injury at disease onset in pediatric anti-NMDAR encephalitis.
  • FBA may offer diagnostic and prognostic value beyond conventional imaging.
  • Further research is warranted to explore FBA as an individualized biomarker.

Related Concept Videos